CLINICAL_TRIALS
trial_result
· 2019-05-17
Clinical Trial Update: A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours [Phase 2]
Summary
A Phase 2 clinical trial in BRCA-defective tumors including breast and ovarian cancer has completed recruitment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Oxford | Conditions: Breast Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-05-17